Drug development: Releasing the brakes

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2013 English Publisher:Springer Science and Business Media LLCJournal:Nature, volume 504, pages S6-S8 (issn: 0028-0836, eissn: 1476-4687,

Copyright policy )

Authors: Karen, Weintraub;

doi: 10.1038/504s6a

pmid: 24352363

Drug development: Releasing the brakes

- Summary
- Subjects
- Metrics

Abstract

Tumours can put a brake on the immune system, but new therapies work by removing these brakes. Now, researchers have to figure out how to use them most effectively.

Keywords

Clinical Trials as Topic, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Ipilimumab, Mice, Nivolumab, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Drug Discovery, Immune Tolerance, Animals, Humans, Female, Immunotherapy, Melanoma

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	20
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%